Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Erastin as a Ferroptosis Inducer: Protocols and Advances
2026-04-15
Erastin, a potent ferroptosis inducer from APExBIO, is central to dissecting iron-dependent cell death in RAS/BRAF-mutant cancers. This article details optimized workflows, troubleshooting strategies, and real-world assay innovations informed by cutting-edge research.
-
Z-VDVAD-FMK: Dissecting Caspase-2 Pathways in Viral and Apop
2026-04-14
Explore how Z-VDVAD-FMK enables advanced caspase-2 pathway dissection in both apoptosis and antiviral research. This article uniquely bridges mitochondrial mechanisms and recent host-virus discoveries, offering deeper scientific context for benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone users.
-
Dibutyryl-cAMP, Sodium Salt: Mechanistic Insights & Benchmar
2026-04-13
Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) is a cell-permeable, stable analog of cAMP used to dissect cAMP signaling pathway research. This article details its validated mechanism, protocol benchmarks, and common misconceptions, offering a rigorous, evidence-based resource for researchers.
-
FLOT1–FOSL2–EphA2 Axis Regulates Microglial Polarization in
2026-04-13
This study identifies the interaction of FLOT1 and FOSL2 as a key driver of EphA2-mediated microglial polarization and neuroinflammation in Alzheimer's disease models. Targeting this axis may represent a new strategy for modulating neurotoxic inflammation and improving cognitive outcomes in neurodegenerative disease research.
-
ATRX Loss Increases Glioma Sensitivity to RTK/PDGFR Inhibito
2026-04-12
Pladevall-Morera et al. (2022) demonstrate that high-grade glioma cells deficient in ATRX are markedly more sensitive to receptor tyrosine kinase (RTK) and PDGFR inhibitors. This finding suggests ATRX status may be a critical biomarker for stratifying glioma patients in clinical trials targeting kinase pathways.
-
CD28-ARS2 Axis Controls PKM Splicing for CD8+ T Cell Flexibi
2026-04-12
This study reveals that the CD28-ARS2 signaling axis promotes alternative splicing of pyruvate kinase, favoring PKM2 isoform expression and granting CD8+ T cells crucial metabolic flexibility for antitumor immunity. The work uncovers a PI3K-independent mechanism for metabolic reprogramming, with broad implications for immunometabolism research.
-
Erastin: Ferroptosis Inducer Workflows for Cancer Biology
2026-04-11
Erastin, a benchmark ferroptosis inducer from APExBIO, powers advanced cancer biology research by enabling precise, iron-dependent cell death modeling in RAS/BRAF-mutant tumor cells. This guide details optimized workflows, troubleshooting strategies, and actionable protocol enhancements to maximize experimental success with Erastin.
-
Caspase-8 Fluorometric Assay Kit: Advanced Apoptosis Workflo
2026-04-11
The Caspase-8 Fluorometric Assay Kit empowers high-sensitivity, quantitative apoptosis assays in both cancer and neurodegenerative disease models. Built on robust IETD-dependent detection, it streamlines experimental design and troubleshooting for researchers investigating programmed cell death.
-
Temsirolimus (CCI-779): Practical Guide for Cancer Research
2026-04-10
Temsirolimus (CCI-779) is a potent, cell-permeable mTOR inhibitor designed for preclinical cancer research, particularly in breast cancer proliferation assays, xenograft models, and PTEN mutant tumor studies. It is not suitable for diagnostic or clinical applications. Proper handling and protocol precision are critical to experimental success.
-
Tioconazole: Mechanistic Insights and Novel Applications ...
2026-04-10
Explore how Tioconazole, a leading antifungal medication, advances fungal infection research through deep mechanistic analysis and innovative experimental applications. This article uniquely connects ergosterol biosynthesis inhibition with emerging insights into cellular metabolism and genomic stability.
-
BMX-IN-1: Advancing Translational Research Through Select...
2026-04-09
This thought-leadership article explores the transformative potential of BMX-IN-1, a highly selective, irreversible BMX kinase inhibitor, for translational researchers at the intersection of cancer biology, angiogenesis, and host-directed infectious disease therapy. We synthesize the latest mechanistic findings—including the newly elucidated role of BMX in lysosomal acidification modulation during Mycobacterium tuberculosis infection—while charting actionable guidance for study design, workflow integration, and future therapeutic innovation.
-
Epalrestat: Mechanistic Insights and Advanced Research Ap...
2026-04-08
Explore the advanced molecular mechanisms of Epalrestat, a leading aldose reductase inhibitor, in neuroprotection and diabetic complication research. This article uniquely dissects its dual action on the polyol pathway and KEAP1/Nrf2 signaling, providing new perspectives for oxidative stress and neurodegenerative disease modeling.
-
Epalrestat: High-Purity Aldose Reductase Inhibitor for Di...
2026-04-08
Epalrestat is a high-purity aldose reductase inhibitor used in diabetic complication and neuroprotection research. It directly targets the polyol pathway and activates the KEAP1/Nrf2 antioxidant pathway, enabling reproducible results in oxidative stress and Parkinson’s disease models. APExBIO supplies Epalrestat (SKU B1743) for research use only.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Apopt...
2026-04-07
The Annexin V-FITC/PI Apoptosis Assay Kit delivers robust, one-step detection and clear discrimination between early apoptosis, late apoptosis, and necrosis. Its versatility across cancer, infection, and wound-healing models sets it apart for high-fidelity, reproducible cell death pathway analysis.
-
BMX-IN-1: Precision BMX Kinase Inhibition for Advanced Ca...
2026-04-07
Explore BMX-IN-1, a highly selective BMX kinase inhibitor, as an advanced tool for cancer research and host-pathogen studies. This article uniquely analyzes BMX-IN-1’s role in modulating signaling, angiogenesis, and lysosomal pathways, offering deeper scientific insights than existing resources.